Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours
Conditions
Lung Neoplasms - Lung Cancer
Conditions: official terms
Carcinoma, Non-Small-Cell Lung - Lung Neoplasms
Conditions: Keywords
lung neoplasms, metastatic lung cancer, stereotactic radiation
Study Type
Interventional
Study Phase
Phase 1/Phase 2
Study Design
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Intervention
Name: Fractionated Stereotactic Radiotherapy
Type: Procedure
Overall Status
Recruiting
Summary
Medically inoperable lung cancer or metastatic lung tumours will be treated with fractionated stereotactic radiation using a schedule of 1) 12 Gy x 4 treatments or 2) 6 Gy x 10 treatments.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- non-small cell lung cancer less than 6cm; no mediastinal or distant metastases

- Open to Alberta,Canada Residents

Exclusion Criteria:

- tumour size greater than 6cm; inadequate pulmonary function(ie. FEV1 less than 0.8 L), Karnofsky performance status less than 70, multiple co-morbid conditions
Location
Tom Baker Cancer Center
Calgary, Alberta, Canada
Status: Recruiting
Contact: Marilyn David - 403-521-3619 - marilyn.david@albertahealthservices.ca
Start Date
September 2006
Sponsors
Alberta Health Services
Source
AHS Cancer Control Alberta
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page